Cargando…
FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
Human epidermal growth factor receptor 1 or 2 (HER1/2), and fibroblast growth factor receptor 1 (FGFR1) signaling serve critical roles in the progression of breast cancer; however, cross-talk between HER1/2 and FGFR1 signaling has not been extensively studied. In the present study, the copy number v...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950032/ https://www.ncbi.nlm.nih.gov/pubmed/29805554 http://dx.doi.org/10.3892/ol.2018.8423 |